Crossmark

Current Trends in the Clinical Development of Antibody-Drug Conjugates in Oncology

Crossref DOI link: https://doi.org/10.1007/s40290-018-0238-6

Published Online: 2018-06-28

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dott, Joseph https://orcid.org/0000-0002-6066-5798
Abila, Bams

Wuerthner, Jens U.
License Information

Text and Data Mining valid from 2018-06-28
More Information

Article History

First Online: 28 June 2018

Compliance with Ethical Standards

:

: No funding was received for the completion of this work.

: Joseph Dott and Bams Abila declare that they have no conflict of interest. Jens Wuerthner is an employee ADC Therapeutics, a company developing PBD-based ADCs for different indications in oncology.